|
1
|
Fan FF, Xu Q, Sun Q, Zhao SJ, Wang P and
Guo XR: Assessment of the reporting quality of randomized
controlled trials on treatment of coronary heart disease with
traditional chinese medicine from the chinese journal of integrated
traditional and Western medicine: a systematic review. PLoS One.
9:e863602014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Doyle F, Rohde D, Rutkowska A, Morgan K,
Cousins G and McGee H: Systematic review and meta-analysis of the
impact of depression on subsequent smoking cessation in patients
with coronary heart disease: 1990 to 2013. Psychosom Med. 76:44–57.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tully PJ and Baumeister H: Collaborative
care for the treatment of comorbid depression and coronary heart
disease: A systematic review and meta-analysis protocol. Syst Rev.
3:1272014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li SM, Xu H and Chen KJ: Integrative
medicine on coronary heart disease: Annual academic review 2013.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 34:1029–1034. 2014.(In
Chinese). PubMed/NCBI
|
|
5
|
Ray IB, Menezes AR, Malur P, Hiltbold AE,
Reilly JP and Lavie CJ: Meditation and coronary heart disease: A
review of the current clinical evidence. Ochsner J. 14:696–703.
2014.PubMed/NCBI
|
|
6
|
Niermann C, Gorressen S, Klier M, Gowert
NS, Billuart P, Kelm M, Merx MW and Elvers M: Oligophrenin1
protects mice against myocardial ischemia and reperfusion injury by
modulating inflammation and myocardial apoptosis. Cell Signal.
28:967–978. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo CX, Jiang X, Zeng XJ, Wang HX, Li HH,
Du FH and Chen BX: Soluble receptor for advanced glycation
end-products protects against ischemia/reperfusion-induced
myocardial apoptosis via regulating the ubiquitin proteasome
system. Free Radic Biol Med. 94:17–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi ZY, Liu Y, Dong L, Zhang B, Zhao M,
Liu WX, Zhang X and Yin XH: Cortistatin improves cardiac function
after acute myocardial infarction in rats by suppressing myocardial
apoptosis and endoplasmic reticulum stress. J Cardiovasc Pharmacol
Ther. 18:2016.
|
|
9
|
Nishikido T, Oyama J, Shiraki A, Komoda H
and Node K: Deletion of apoptosis inhibitor of macrophage
(AIM)/CD5L attenuates the inflammatory response and infarct size in
acute myocardial infarction. J Am Heart Assoc. 5:e0028632016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Volkman R and Offen D: Concise review:
Mesenchymal stem cells in neurodegenerative diseases. Stem Cells.
35:1867–1880. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma T, Sun J, Zhao Z, Lei W, Chen Y, Wang
X, Yang J and Shen Z: A brief review: Adipose-derived stem cells
and their therapeutic potential in cardiovascular diseases. Stem
Cell Res. 8:1242017. View Article : Google Scholar
|
|
12
|
Kane C and Terracciano CMN: Concise
review: Criteria for chamber-specific categorization of human
cardiac myocytes derived from pluripotent stem cells. Stem Cells.
35:1881–1897. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu X, Xia R, Zhang B and Gao F: MRI
tracking stem cells transplantation for coronary heart disease. Pak
J Med Sci. 30:899–903. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu YH, Wu HQ and Qi X: Influence of shenfu
injection on heart function and bone marrow stem cell mobilization
in patients with chronic heart failure of coronary heart disease.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 29:309–312. 2009.(In Chinese).
PubMed/NCBI
|
|
15
|
Ghem C, Dias LD, Sant'Anna RT, Kalil RAK,
Markoski M and Nardi NB: Combined analysis of endothelial,
hematopoietic, and mesenchymal stem cell compartments shows
simultaneous but independent effects of age and heart disease. Stem
Cells Int. 2017:52376342017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dirani M, Nasreddine W, Abdulla F and
Beydoun A: Seizure control and improvement of neurological
dysfunction in Lafora disease with perampanel. Epilepsy Behav Case
Rep. 2:164–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li D, Wei W, Ran X, Yu J, Li H, Zhao L,
Zeng H, Cao Y, Zeng Z and Wan Z: Lipoprotein-associated
phospholipase A2 and risks of coronary heart disease and ischemic
stroke in the general population: A systematic review and
meta-analysis. Clin Chim Acta. 471:38–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng B, Chen S, Gordon AD and Chakrabarti
S: miR-146a mediates inflammatory changes and fibrosis in the heart
in diabetes. J Mol Cell Cardiol. 105:70–76. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tzatzalos E, Abilez OJ, Shukla P and Wu
JC: Engineered heart tissues and induced pluripotent stem cells:
Macro- and microstructures for disease modeling, drug screening,
and translational studies. Adv Drug Deliv Rev. 96:234–244. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gidron Y, Kupper N, Kwaijtaal M, Winter J
and Denollet J: Vagus-brain communication in
atherosclerosis-related inflammation: A neuroimmunomodulation
perspective of CAD. Atherosclerosis. 195:e1–e9. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bujak M and Frangogiannis NG: The role of
IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp.
57:165–176. 2009. View Article : Google Scholar
|
|
23
|
Li Z and Wu JC, Sheikh AY, Kraft D, Cao F,
Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP and Wu JC:
Differentiation, survival, and function of embryonic stem cell
derived endothelial cells for ischemic heart disease. Circulation.
116:I46–54. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu ZW, Liu YF, Wang S and Li B: miRNA-146a
induces vascular smooth muscle cell apoptosis in a rat model of
coronary heart disease via NF-kappaB pathway. Genet Mole Res.
14:18703–18712. 2015. View Article : Google Scholar
|
